Medicus Pharma's microneedle patch targets a $15B skin cancer market with a non-invasive, cost-effective alternative to surgery.
Share this post
Investing Deep Dive: Medicus Pharma Ltd…
Share this post
Medicus Pharma's microneedle patch targets a $15B skin cancer market with a non-invasive, cost-effective alternative to surgery.